The ATP sensitive potassium channel (K(ATP)) is a novel target for migraine drug development

Migraine is one of the leading causes of disability worldwide, affecting work and social life. It has been estimated that sales of migraine medicines will reach 12.9 billion USD in 2027. To reduce social impact, migraine treatments must improve, and the ATP-sensitive potassium (K(ATP)) channel is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Clement, Amalie, Christensen, Sarah Louise, Jansen-Olesen, Inger, Olesen, Jes, Guo, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338883/
https://www.ncbi.nlm.nih.gov/pubmed/37456521
http://dx.doi.org/10.3389/fnmol.2023.1182515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338883/
https://www.ncbi.nlm.nih.gov/pubmed/37456521
http://dx.doi.org/10.3389/fnmol.2023.1182515

Ejemplares similares